Agentix Corp.
AGTX
Rank in Stocks
#32644
Agentix Corp., a company in the clinical development phase, specializes in the... Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases. The company was founded in 2013, initially known as FairWind Energy, Inc., before officially changing its name to Agentix Corp. in June 2019. Its operations are based in Dana Point, California.
Share Price
$0.0337
Last synced: 2026-11-10
Market Cap
$1.35M
Change (1 day)
0.00%
Change (1 year)
-24.94%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Agentix Corp. (AGTX)
Category
Healthcare
Operating Margin for Agentix Corp. (AGTX)
Operating Margin as of November 2026 TTM: 0.00%
According to Agentix Corp.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Agentix Corp. from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2023 | 0.00% | -100.00% |
| 2021 | -108,147.66% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | -100.00% |
| 2017 | -14,844.00% | 2,089.96% |
| 2016 | -677.82% | 9.83% |
| 2015 | -617.18% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Agentix Corp.'s operating margin
What was Agentix Corp.'s operating margin in 2025?
In 2025, Agentix Corp.'s operating margin was 0.00%, compared with 0.00% in 2023.
How has Agentix Corp.'s operating margin changed since 2020?
From 2020 to 2025, Agentix Corp.'s operating margin was highest in 2025 (0.00%) and lowest in 2021 (-108,147.66%).
How does Agentix Corp.'s operating margin compare with similar companies?
Agentix Corp.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.